Cancer Drugs Archives - Express Pharma

XTANDI-Leuprolide boosts survival in non-metastatic hormone sensitive high risk Prostate cancer: Phase 3 EMBARK Trial

Industry leaders hail GST Reduction on Cancer Drugs to 5%

Glenmark and BeiGene partner to market cancer drugs in India

AstraZeneca bets on new cancer treatments with $2 billion Fusion Pharma purchase

Venus Remedies gets marketing approvals from Oman, Malaysia, Bosnia and Trinidad & Tobago

Venus Remedies gets marketing approval for cancer drugs from Uzbekistan, Palestine

Finland’s Orion to focus on cancer and pain drugs

Existing cancer drugs to be trialled as new treatment for breast cancer

Merck KGaA signs deal with Artios Pharma for cancer drugs research

Roche gets US FDA approval for Tecentriq combo to treat advanced melanoma